StockWatch
·
Biotechnology: Pharmaceutical Preparations
OtherMar 29, 2026, 08:56 PM

Novartis AG Files Annual Report 2025 and Report on Nonfinancial Matters 2025

AI Summary

Novartis AG filed its annual report for 2025 and a report on nonfinancial matters. These reports provide investors with insights into the company's financial performance and its environmental, social, and governance (ESG) activities, which are increasingly important for investment decisions.

Key Highlights

  • Filing includes the Annual Report 2025 (Exhibit 99.1).
  • Filing includes the Report on Nonfinancial Matters 2025 (Exhibit 99.2).
  • These reports are key for investors to assess Novartis' overall performance and sustainability efforts.